180
Participants
Start Date
March 1, 2022
Primary Completion Date
December 31, 2030
Study Completion Date
Mepolizumab
Monoclonal antibodies
RECRUITING
Ghent University Hospital, Ghent
University Hospital, Ghent
OTHER